Founded in 2015 by Yulin Weng and headquartered in Suzhou, Jiangsu Province, China, DK Medtech is dedicated to enhancing patients’ quality of life through cutting-edge technologies and innovative medical solutions. With a comprehensive product portfolio spanning coronary, peripheral, and neurovascular interventions, we deliver high-quality therapeutic options for global patients.
Technological Leadership
As a pioneer in full-range vascular interventions, DK Medtech has developed over 10 balloon catheter types including conventional balloons, high-pressure balloons, scoring balloons, and drug-coated scoring balloons. Our proprietary Directional Scoring Technology demonstrates superior clinical benefits in coronary/peripheral scoring balloons and DCBs, outperforming imported counterparts in pre-market RCT studies. Strategic collaborations with Medtronic and Asahi Intecc further validate our market position.
Operational Excellence
With a 500+ multidisciplinary team, DK Medtech operates a 12,000㎡ global manufacturing center and 9,200㎡ R&D hub. Our achievements include:
– National Recognition: National High-tech Enterprise, Jiangsu Potential Unicorn, Suzhou Unicorn Cultivation Enterprise
– Industry Accolades: Top 100 Medical Innovations (2024), China Biopharma Leader TOP100 (2024), Venture50 Rising Star (2023)
– Certifications: ISO 13485, MDSAP, GB/T29490 Intellectual Property Compliance
Strategic Growth
Backed by premier investors including Qiming Venture Partners, Legend Capital, and CICC Capital, DK Medtech has secured six rounds of financing exceeding USD 100 million, accelerating global commercialization of our innovative pipeline.
